Connective Tissue Diseases Flashcards

1
Q

underlying pathology behind systemic sclerosis

A

excessive collagen deposition causing skin and internal organ changes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Condition most associated with systemic sclerosis

A

Raynauds

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

3 phases of cutaneous involvedment in systemic sclerosis

A

oedematous, indurative, atrophic –> skin thickened and tight

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Organs affected in systemic sclerosis

A

lungs, kidneys, gut

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Affect of systemic sclerosis on the lungs

A

pulmonary fibrosis and hypertension

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Effect of systemic sclerosis on the kidneys

A

increased hypertension –> renal crisis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Effect of systemic sclerosis on the gut

A

dysphagia, malabsorption, reflux, dysmotility

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Systemic sclerosis can be split into…

A

limited and diffuse

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Limited cutaneous sclerosis can be described by CREST, which stands for…

A

Calcinosis of the subcutaneous tissues, Raynauds, oEsophageal and gut dysmotility, Sclerodactyl, Telangiectasia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Where is skin involvement limited to in limited systemic sclerosis?

A

face, hands and feet

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Autoantibody associated with limited systemic sclerosis?

A

Anti-centromere (70-80%), ANA

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Diffuse systemic sclerosis is…

A

rapid and widespread skin changes with early and significant organ involvement

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Autoantibody associated with diffuse systemic sclerosis?

A

Anti-scl70 (topoisermerase), ANA

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Investigations for systemic sclerosis

A

auto-antibodies, organ screening (lungs, kidneys, heart)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Management of Raynauds in systemic sclerosis

A

Calcium channel blockers, iloprost (PGI2 analogue), bosentan (endothelin R antagonist)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Management of renal involvement in systemic sclerosis

A

ACE-Is (ramipril), ARBs (losartan)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Management of GI involvement in systemic sclerosis

A

PPIs - against reflux

18
Q

Management of ILD in systemic sclerosis

A

immunosuppression - cyclophosphamide

19
Q

main organs affected by SLE

A

skin, joints, kidneys, blood cells and nervous system

20
Q

What is the pathogenic mechanism behind SLE?

A

due to defect in apoptosis, increased cell death but also a delay in clearance of dead cells leads to persistence of antigens i.e. dsDNA and thus immune complex production. antibody-antigen complexes are deposited in the basement membranes of skin and kidneys

21
Q

The majority of SLE is in which group?

A

Women (11:1), 20-30 years

22
Q

General presentation of SLE (get 5/6)

A

fatigue, weightloss, fever, arthralgia, myalgia, malar rash, discoid lupus, ulceration, lupus nephritis, pleurisy/pleural effusion, leukopaenia, anaemia, pericarditis, autoimmune hepatitis

23
Q

Immunology for SLE diagnosis

A

ANA (95%, non-specific), anti-dsDNA (specific and varies with activity), anti-sm (specific but low sensitivity), C3/C4 (low when disease is active)

24
Q

What investigations should be done for SLE (3)?

A

Bloods (anaemia, leucopaenia, thrombocytopaenia), urinalysis (nephritis), immunology

25
Q

Management of SLE with skin and arthralgia

A

hydroxychlorquine, topic steroids and NSAIDs

26
Q

Mechanism of action of hydroxychloroquine

A

blocks APCs

27
Q

Management of SLE with organ involvement

A

immunosuppression with azathioprine or mycofenolate mofetil

28
Q

Management of SLE with severe organ involvement

A

IV steroids and cyclophosphamide

29
Q

Monitoring carried out with SLE

A

anti-dsDNA, BP, cholesterol, urinalysis

30
Q

What is the pathogenic mechanism in sjogrens syndrome?

A

lymphocitic infiltrates form in exocrine organs

31
Q

Common symptoms associated with sjogrens syndrome?

A

dry eyes and mouth, arthralgia, fatigue, vaginal dryness, parotid gland swelling

32
Q

Associated conditions with SLE

A

RA and SLE

33
Q

Which cancer risk is increased with SLE?

A

lymphoma

34
Q

Diagnosis of sjogrens syndrome is based on?

A

Anti-Ro and Anti-La antibodies and Schimers test

35
Q

Management of sjogrens is by…

A

symptomatic relief, eye drops, pilocarpine to stimulate saliva production, hydroxychloroquine to aid arthralgia and fatigue

36
Q

what is antiphospholipid syndrome?

A

a disorder that clinically manifests as recurrent venous or arterial thromboembolism

37
Q

Antibodies associated with antiphospholipid syndrome

A

Anti-cardiolipin, anti- b2glycoprotein

38
Q

Signs of Antiphospholipid syndrome

A

increased frequency of stroke or MI, recurrent pulmonary emboli, catastrophic APS, late spontaneous fetal loss, recurrent fetal loss (<10weeks), migraines, livedo reticularis (skin)

39
Q

Management of symptomatic Antiphospholipid patients?

A

anti-coagulation

40
Q

Management of symptomatic pregnant antiphospholipid patients

A

LMWH (dalteparin, enoxaparin) - warfarin is teratogenic

41
Q

Management of asymptomatic antiphospholipid patients

A

no anticoagulation

42
Q

what is catastrophic APS?

A

rare, serious and often fatal (50%) manifestation with multiple organ infarcts over days to weeks